AzTrials
AzTrials

Psychological TraumaNCT04528589

To Repeat or Not to Repeat - Preventing Intergenerational Transfer of Adverse Childhood Experiences

An observational study of Psychological Trauma, run by University Hospital, Akershus at 1 site in Norway.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The main aim of the study is to examine patients' and therapists' experiences with prenatal psychotherapy provided to pregnant women with adverse childhood experiences and how this may influence intergenerational transmission of risk. Read more about this study

Who is it for?
Ages 18 years and older, women only
Conditions the study is for
Psychological Trauma
What is being tested?
prenatal psychotherapy
How many people
23 participants
Where
1 siteNorway
Study dates
24 Aug 2020to 12 Feb 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • Women only
  • No healthy volunteers
  • Adult, Older adult

Study population: Mothers: Clinically referred pregnant women with adverse childhood experiences. Therapists: Therapists providing prenatal psychotherapy to women with adverse childhood experiences

Who may be able to join

  • Clinically referred women in gestational week 20-30
  • Adverse Childhood Experiences Questionnaire (ACE) score of 2 or more

Who cannot join

  • Known IQ below 70
  • Ongoing substance abuse
  • Planned referral to mother-child center after birth

Trial locations and contacts

1 site in 1 country.

Norway1 site
  • BUP Øvre Romerike

    Jessheim

Other trials in Norway

About this study

Official title: To Repeat or Not Repeat - A Mixed Methods Pilot Study of Patients' and Therapists' Experience With Prenatal Psychotherapy to Prevent Intergenerational Transfer of Adverse Childhood Experiences

The main aim of the study is to examine patients' and therapists' experiences with prenatal psychotherapy provided to pregnant women with adverse childhood experiences and how this may influence intergenerational transmission of risk. The investigators will explore a) participants' perspectives on what promoted or prevented change in psychotherapy, b) how the mothers' reflective function changes and possible factors associated with change in reflective function. Up to 20 clinically referred women in gestational week 20-30 will be included and assessed with qualitative interviews and questionnaires at the beginning of treatment and when the baby is 4 months old. The quality of the mother-infant relationship will be assessed. Seven therapists will be interviewed with a qualitative interview schedule. Outcomes of the study will inform individual tailoring of psychotherapy for a high risk group of patients and provide increased knowledge about how intergenerational risk factors change during treatment.

Read the detailed description

Even with the best evidence-based treatments, one is often unsuccessful in stopping intergenerational transfer of trauma, abuse, and neglect. The implications for the next generation are severe, affecting physical and emotional health, cognitive development, and relational functioning. The perinatal phase may provide a window of opportunity in efforts to prevent intergenerational transfer of risk factors associated with adverse childhood events. There is a great need for more knowledge about how generational patterns develop and are affected by psychotherapy during pregnancy, infancy and early childhood. Little is known about patients' experiences with prenatal psychotherapy and such knowledge can inform better tailoring of treatment. The present study is the first step of a planned longitudinal study to explore the role of mothers' adverse childhood experiences and child development.

The primary aim of the study is to explore patients' experiences with prenatal psychotherapy provided to pregnant women with adverse childhood experiences and their perspectives of what promotes or hinders change in treatment. Second, aims of the study are to explore a) therapists' experiences with psychotherapy for mothers with adverse childhood experiences, and b) explore the development of intergenerational risk factors. Additionally the investigators will explore the mothers' reflective function during the course of treatment, the role of adverse and benevolent childhood memories, and mother-infant interaction when the infant is four months old. Reflective function seems to be a key factor associated with quality of care in spite of adverse events. Understanding factors associated with possible change in reflective function is thus highly important. Up to 20 clinically referred women in gestational week 20-30 will be recruited. Participants will be assessed at the beginning of therapy and when the child is four months old. A combination of quantitative measures and qualitative interviews will be used. The infant will be assessed with the neonatal assessement scale at age 4-8 weeks and the quality of the mother-infant relationship will be assessed using Parent-Child Relation Assessment at four months. In addition, seven therapists will be interviewed about their experiences providing psychotherapy for this group of high risk patients.

Being tested
prenatal psychotherapy
Keywords
Mother-child relations, parenting, reflective function, child development, psychotherapy
Medical subject headings
Psychological Trauma

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • prenatal psychotherapyOther

    Prenatal psychotherapy to break intergenerational risk of adverse childhood events

Study groups in NCT04528589
Study groupRoleWhat they receive
MothersWomen with adverse childhood experiences referred for treatment in gestational week 20-30
Receives: Other: prenatal psychotherapy
TherapistsClinicians with experience of providing psychotherapy to women with adverse childhood experiences referred for treatment during pregnancy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Experiences with prenatal psychotherapy

    Qualitative interview conducted 4 months after birth examining the mothers' experiences with the treatment

    Measured: 4 months after birth

Secondary outcomes (2)
  1. Maternal Reflective functioning - Parent Development Interview

    Assessment of change in mother's reflective functioning, higher score indicates better functioning.

    Measured: Gestational week 20-30 to 4 months after birth

  2. Therapists' experiences with providing psychotherapy for women with adverse childhood events

    A qualitative interview examining positive and negative experiences with providing prenatal psychotherapy to women to prevent intergenerational transmission of adverse childhood events

    Measured: Through study completion, an average of 1 year

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Aug 2020
  2. Study start24 Aug 2020
  3. Primary completion23 Feb 2023
  4. Study completion12 Feb 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Case only
Time perspective
Prospective
Enrolment
23 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT04528589
Sponsor's protocol ID
97191
Status last verified
Apr 2026
First submitted
16 Jul 2020
Last updated
4 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Fjeldheim H, Werner A, Anke T, Moe V, Norheim HS, Aalberg M. Parenting the parent without losing sight of the child. A qualitative study of therapists' experiences with intergenerational adversities in perinatal psychotherapy. Infant Ment Health J. 2024 Mar;45(2):201-216. doi: 10.1002/imhj.22100. Epub 2024 Jan 25.

    PubMed 38272852

Questions about this trial

What is this clinical trial studying?

An observational study of Psychological Trauma, run by University Hospital, Akershus at 1 site in Norway.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 4 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Norway. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Experiences with prenatal psychotherapy (time frame: 4 months after birth). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT04528589, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 4 May 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in